Versor Investments LP purchased a new position in shares of PACS Group, Inc. (NYSE:PACS – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 14,127 shares of the company’s stock, valued at approximately $542,000.
Several other large investors have also made changes to their positions in PACS. Crewe Advisors LLC boosted its position in shares of PACS Group by 93.1% during the 4th quarter. Crewe Advisors LLC now owns 2,147,815 shares of the company’s stock worth $82,455,000 after acquiring an additional 1,035,747 shares in the last quarter. Alyeska Investment Group L.P. acquired a new stake in shares of PACS Group during the 3rd quarter worth approximately $11,904,000. Royce & Associates LP boosted its position in PACS Group by 76.6% in the third quarter. Royce & Associates LP now owns 1,859,070 shares of the company’s stock valued at $25,525,000 after buying an additional 806,446 shares in the last quarter. Marshall Wace LLP boosted its position in PACS Group by 348.6% in the third quarter. Marshall Wace LLP now owns 1,010,906 shares of the company’s stock valued at $13,880,000 after buying an additional 785,537 shares in the last quarter. Finally, Ameriprise Financial Inc. boosted its position in PACS Group by 120.4% in the second quarter. Ameriprise Financial Inc. now owns 1,129,612 shares of the company’s stock valued at $14,595,000 after buying an additional 617,124 shares in the last quarter.
PACS Group Price Performance
Shares of NYSE PACS opened at $41.14 on Thursday. PACS Group, Inc. has a twelve month low of $7.50 and a twelve month high of $43.08. The firm has a fifty day simple moving average of $34.22 and a 200 day simple moving average of $32.43. The company has a market capitalization of $6.51 billion, a PE ratio of 26.37, a P/E/G ratio of 1.25 and a beta of -0.03. The company has a quick ratio of 1.07, a current ratio of 0.99 and a debt-to-equity ratio of 0.27.
Analyst Upgrades and Downgrades
PACS has been the topic of a number of research analyst reports. Oppenheimer raised their target price on shares of PACS Group from $42.00 to $48.00 and gave the company an “outperform” rating in a research report on Wednesday. UBS Group raised their target price on shares of PACS Group from $42.00 to $44.00 and gave the company a “buy” rating in a research report on Wednesday, March 4th. Zacks Research upgraded shares of PACS Group from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, March 4th. Royal Bank Of Canada raised their target price on shares of PACS Group from $47.00 to $52.00 and gave the company an “outperform” rating in a research report on Friday, February 27th. Finally, Wall Street Zen upgraded shares of PACS Group from a “hold” rating to a “buy” rating in a research report on Sunday. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of $45.60.
Check Out Our Latest Stock Analysis on PACS Group
Insiders Place Their Bets
In related news, COO Joshua Jergensen sold 36,335 shares of PACS Group stock in a transaction on Friday, March 13th. The shares were sold at an average price of $34.28, for a total transaction of $1,245,563.80. Following the completion of the transaction, the chief operating officer owned 2,667,347 shares of the company’s stock, valued at $91,436,655.16. This trade represents a 1.34% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 70.10% of the stock is owned by corporate insiders.
PACS Group Company Profile
PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.
Further Reading
- Five stocks we like better than PACS Group
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.
